46.36
46.36 (0.48%)
As of Mar 06, 2024
IDEAYA Biosciences, Inc. [IDYA]
Source:
Company Overview
Ideaya Biosciences, Inc is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | 650-443-6209 |
| Industry | manufacturing |
| CEO | Yujiro Hata |
| Website | www.clinicaltrials.gov |